Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Apple Tree Partners (ATP) is a venture capital firm founded in 1999 and based in the United States. The firm focuses on life sciences, particularly the development of biotechnology companies. ATP creates and invests in companies at various stages, from pre-IP ideas to asset spinouts, providing flexible capital and strategic resources to build sustainable, research-driven enterprises.
As of now, ATP manages a portfolio of 30 companies, showcasing its commitment to the life sciences sector. The firm has established itself as a key player in the biotechnology landscape, leveraging its expertise to support innovative companies. ATP's team consists of experienced professionals with backgrounds in medicine, finance, and operations, enhancing their ability to guide portfolio companies effectively.
ATP invests exclusively in life sciences companies, supporting them from seed stage through IPO and beyond. Their investment strategy emphasizes collaboration with scientists on pre-IP ideas and facilitating spinouts from existing company pipelines. This approach allows ATP to identify and nurture innovative concepts that have the potential to transform the healthcare landscape.
The firm typically invests across multiple stages, including Seed, Series A, Series B, Series C, Pre-IPO, and IPO. ATP's check sizes vary depending on the stage of investment, providing flexibility to meet the needs of emerging biotech companies. Their geographic focus is primarily on the United States, where they seek to partner with visionary founders and teams dedicated to advancing life sciences.
ATP's portfolio includes a diverse range of biotechnology companies, reflecting its commitment to innovation in life sciences. Notable portfolio companies include:
This extensive portfolio highlights ATP's focus on supporting innovative companies that are poised to make significant contributions to the healthcare industry.
Seth L. Harrison, MD - Founder and Managing Partner. Dr. Harrison has extensive experience in the life sciences sector and has led numerous successful investments.
Marie-Therese Afif - Head of Operations. Afif oversees the operational aspects of ATP, ensuring efficient management of the firm's portfolio.
Anna Batarina, CFA - Partner. Batarina brings financial expertise and has been involved in various successful funding rounds.
Paul Eisenberg, MD - Chief Medical Officer and Venture Partner. Dr. Eisenberg provides medical insights and guidance to portfolio companies.
Daniel Finkelman - General Counsel. Finkelman handles legal matters and compliance for ATP.
Sally Jacob - Head of Communications. Jacob manages ATP's communications strategy and public relations.
Neena Kadaba, PhD - Team member with expertise in life sciences.
Spiros Liras, PhD - Team member with a strong background in biotechnology.
Stephanie Maiocco, PhD - Team member specializing in research and development.
Mark Mitchnick, MD - Team member with extensive medical experience.
Vern Norviel - Team member contributing to operational strategies.
John F. Reilly, PhD - Team member with a focus on scientific innovation.
Aileen Salares, CFA - Team member with financial expertise.
Brian Vash - Team member involved in investment strategies.
Joseph A. Yanchik III - Team member contributing to portfolio management.
Eva Zhou - Team member with a focus on market analysis.
To pitch ATP, founders should send their materials via email to info@appletreepartners.com. A concise pitch deck that includes key information about the startup, market analysis, and team background is essential. Response times may vary, but founders can expect feedback within a few weeks.
What investment criteria does ATP look for?
ATP seeks to invest in life sciences companies at various stages, from seed to IPO. They focus on innovative biotechnology firms that demonstrate strong scientific foundations and potential for growth.
How can I apply or pitch to ATP?
Founders can reach out to ATP via email at info@appletreepartners.com. A well-prepared pitch deck that outlines the business model, market opportunity, and team is essential.
What makes ATP different from other venture capital firms?
ATP's deep expertise in life sciences and their commitment to supporting companies from inception through IPO set them apart. They provide flexible capital and strategic resources tailored to the needs of biotech startups.
What is ATP's geographic scope?
ATP primarily focuses on investments within the United States, targeting innovative life sciences companies that are positioned for growth in the domestic market.
What is ATP's post-investment involvement like?
ATP actively engages with portfolio companies, offering mentorship, operational support, and access to their extensive network in the life sciences sector. They aim to facilitate growth and innovation throughout the investment lifecycle.
What are ATP's typical check sizes?
ATP invests across multiple stages, with check sizes varying based on the stage of investment. They provide flexible capital to meet the specific needs of each portfolio company.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.